Low Risk References


#1

Aoun, F.
Predicitve factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins.

Scand J Urol 2017;51(1):20-26

Find this article


#2

Bhatta-Dhar, N
NO DIFFERENCE IN SIX-YEAR BIOCHEMICAL FAILURE RATES WITH OR WITHOUT PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY IN LOW RISK PATIENTS WITH LOCALIZED PROSTATE CANCER

Urology 2004;63(3):528-531

Find this article


#3

Bittner, N
Primary causes of death after permanent prostate brachytherapy

IJROBP 2008;72(2):433-440

Find this article


#4

Bolla, M
Results of a cohort of 200 hormone-naïve consecutive patients with prostate cancer treated with I-125 permanent interstital brachytherapy by the same multidisciplinary team.

Ca Radiother 2014;18(7):643-8

Find this article


#5

Boorjian,S
Mayo Clinic Validation of the D'Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy

J. Urology 2008;179(4):1354-1361

Find this article


#6

Bryant, C
Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-=escalated image-guided proton therapy for prostate cancer.

Urology 2015;95(1):422-34

Find this article


#7

Burri, R
Young men have equivalent biochemical outcomes compares with older men after treatment with brachytherapy for prostate cancer

IJROBP 2010;77(5):1315-21

Find this article


#8

Busch, J
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience

BJU Int 2012;110(11):E985-90

Find this article


#9

Coen, J
Comparison of High-Dose-Rate Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis

IJROBP 2012;82(1):e25-e31

Find this article


#10

Coen, J
Comparison of High-Dose-Rate Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis

IJROBP 2012;82(1):e25-e31

Find this article


#11

Critz, F
10-Year disease free survival rates after simultaneous irradiation for prostate cancer with a focus on calulation and methodology

J. Urology 2004;172(6):2232-2338

Find this article


#12

Critz, FA
25-year disease-free survival rate after irradiation for prostate cancer calculated with the prostat specific antigen definition of recurrences used for radical prostatectomy

J Urol 2013;189(3):878-83

Find this article


#13

Crouzet, S
Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncological outcomes and morbidity in 1002 patients

Eur Urol 2013;epub Apr 30():

Find this article


#14

Dearnaley, D
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Lancet Oncol 2016;17(8):1047-60

Find this article


#15

Demanes, D J
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation

Am J. Clinical Oncology 2009;32(4):342-347

Find this article


#16

Diaz, M
Oncological outcomes at 10 years following robotic radical prostatectomy

Eur Urol 2015;67(6):1168-76

Find this article


#17

Dickinson, P
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.

BJU Int 2014;113(5):748-53

Find this article


#18

Ding, W
Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy

IJROBP 2012;84(4):962-7

Find this article


#19

Ellis, R
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (prostascint) in a cohort diagnosed with localized prostate cancer

IJROBP 2010;In Press():

Find this article


#20

Fellin, G.
Low dose rate bachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series o 2237 patients from 11 institutions.

Br J Radiol 2016;89(1065):20150981

Find this article


#21

Fujimura, T
Robot-assisted radical prostectomy significntly reduced biochemical recurrence compared to retro pubic radical prostatectomy.

BMC Cancer 2017;17(1):454

Find this article


#22

Galego, P
Analysis of monotherapy prostate brachytherapy in patients with prostate cancer: initial PSA and gleason are important for recurrence?

IBJU 2015;41(2):353-59

Find this article


#23

Ganzer, R
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.

BJU Int 2013;112(3):322-9

Find this article


#24

Genebes, C
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results

IJROBP 2013;87(4):651-58

Find this article


#25

Gestaut, MM
Low-dose-rate brachytherapy versus cryotherapy in low- and intermediate-risk prostate cancer.

IJROBP 2017;98(1):101-107

Find this article


#26

Hauswald, H.
High-dose-rate monotherapy for localized prostate cancer: 10-year results.

IJROBP 2016;94(4):667-74

Find this article


#27

Hinnen, K
Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I125 Permanent Prostate Brachytherapy

IJROBP 2010;76(5):1433-1438

Find this article


#28

Jabbari, S
EQUIVALENT BIOCHEMICAL CONTROL AND IMPROVED PROSTATE-SPECIFIC ANTIGEN NADIR AFTER PERMANENT PROSTATE SEED IMPLANT BRACHYTHERAPY VERSUS HIGH-DOSE THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY AND HIGH-DOSE CONFORMAL PROTON BEAM RADIOTHERAPY BOOST

IJROBP 2010;76(1):36-42

Find this article


#29

Jabbari, S
EQUIVALENT BIOCHEMICAL CONTROL AND IMPROVED PROSTATE-SPECIFIC ANTIGEN NADIR AFTER PERMANENT PROSTATE SEED IMPLANT BRACHYTHERAPY VERSUS HIGH-DOSE THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY AND HIGH-DOSE CONFORMAL PROTON BEAM RADIOTHERAPY BOOST

IJROBP 2010;76(1):36-42

Find this article


#30

Kane, CJ
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database

Urology 2010;76(3):695-700

Find this article


#31

Katz, A
Quality of life and toxicity after SBRT for organ-confined prostate cancer: 7 year study

Front Oncol 2014;4():301 (6 pgs.)

Find this article


#32

Katz, A
Predicting biochemical disease-free survival after prostate stereotactic body radiotherapy: risk-stratification and patterns of failure.

Front. Oncol 2016;6():168

Find this article


#33

Kittel, J
Long-term efficacy and toxicity of low-dose-rate 125-I prostate brachytherapy as monotherapy in low-, intermediate- and high-risk prostate cancer

IJROBP 2015;92(4):884-93

Find this article


#34

Kuban, D
Long-Term Multi-Institutional Analysis of Stage T1-T2 Prostate Cancer Treated with Radiotherapy in the PSA Era

IJROBP 2003;57(4):915-928

Find this article


#35

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ?72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#36

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ?72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#37

Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ?72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer

IJROBP 2004;58(1):25-33

Find this article


#38

Louis, AS
Oncologic outcomes following radical prostatectomy in the active surveillance era.

Can Urol Assoc J 2013;7(7,8):E475-80

Find this article


#39

Marshall, R
Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center

Urol Oncol 2013;32(1):38e1-7

Find this article


#40

Martin, A-G
Permanent Prostate Implant Using High Activity Seeds & Inverse Planning With Fast Simulated Annealing Algorithum: A 12-Year Canadian Experience

IJROBP 2007;67(2):334-341

Find this article


#41

Martinez, E
Permanent seed brachytherapy for clinically localized Prostate Cancer: Long-term outcomes in a 700 patient cohort.

Brachytherapy 2015;14(2):166-72

Find this article


#42

Martinez, P.
Comparison of the biochemical recurrence risk between radical prostatectomy and brachytherapy in the treatment of low- and intermediate-risk prostate cancer.

Arch esp urology 2015;68(8):655-60

Find this article


#43

McLaren, DB
The Importance of Prostate-specific-antigen (PSA) Nadir and Early identification of PSA relapse after 10 years of prostate Iodine 125 seed brachytherapy in Edinburgh

Clin Oncol 2015;27(9):519-26

Find this article


#44

Menon, M
Biochemical Recurrence Following Robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up

Eur. Urol. 2010;58():838-46

Find this article


#45

Merrick, G
Prognostic Significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy

J. Urology 2005;66(5):1048-1053

Find this article


#46

Merrick, G
Androgen deprivation therapy dose not impact cause specific overall survival after permanent prostate brachytherapy

IJROBP 2006;65(3):669-677

Find this article


#47

Michalski, J
Clinical outcomes of patients treated with 3D conformal radaiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

IJROBP 2012;83(3):e363-70

Find this article


#48

Morris, WJ
Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate Cancer

Urology 2009;73():860-867

Find this article


#49

Morris, WJ
Population-based 10-year oncological outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer

Cancer 2013;119(8):1537-46

Find this article


#50

Moyad, M
STATINS, ESPECIALLY ATORVASTATIN, MAY FAVORABLY INFLUENCE CLINICAL PRESENTATION AND BIOCHEMICAL PROGRESSION-FREE SURVIVAL AFTER BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER

Urology 2005;66(6):1150-1154

Find this article


#51

Mullins, JK
Radical Prostatectomy Outcome in Men 65 Years Old or Older With Low Risk Prostate Cancer

J Urol 2012;187(5):1620-25

Find this article


#52

Mullins, JK
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.

J Urol 2012;188(6):2205-10

Find this article


#53

Nguyen, P
Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer

Cancer 2008;113(11):3146-3152

Find this article


#54

Ohashi, T
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation

Radiother & Oncol 2013;109():241-45

Find this article


#55

Pickles, T
Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A single-Institution Matched Pair Analysis

IJROBP 2010;76(1):43-49

Find this article


#56

Pickles, T
Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A single-Institution Matched Pair Analysis

IJROBP 2010;76(1):43-49

Find this article


#57

Potters, l
12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients With Clinically Localized Prostate Cancer

J. Urology 2005;173():1562-1566

Find this article


#58

Rasmusson, E
Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancer.

Acta Oncol 2016;55(8):1016-21

Find this article


#59

Raziee, H
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.

Radiother & Oncol 2017;123(3):459-65

Find this article


#60

Rice, K
Low risk prostate cancer in men > 70 years old: to treat or not to treat.

Urol Oncol 2013;31(6):755-60

Find this article


#61

Rossi, C
Conformal Proton Beam Radiation Therapy for Prostate Cancer: Concepts & Clinical Results

Commun Oncol 2007;4():235-240

Find this article


#62

Sabolch, A
Gleason Pattern 5 is the Greatest Risk Factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation

IJROBP 2011;81(4):e351-60

Find this article


#63

Schreiber, D
Clincal and biochemical outcomes for men undergoing radical prostatectomy or radiation therapy for localized prostate cancer.

Raidat Oncol 2015;33(1):21-28

Find this article


#64

Schreiber, D
Clincal and biochemical outcomes for men undergoing radical prostatectomy or radiation therapy for localized prostate cancer.

Raidat Oncol 2015;33(1):21-28

Find this article


#65

Sekiguchi, A
125 Iodine monotherapy for Japanese men with low-and intermediate-risk prostate cancer: outcomes after 5-years of follow-up.

J Radiat Res. 2014;55(2):328-33

Find this article


#66

Shiraishi, Y
A dose-response analysis of biochemical control outcomes after 125-I monotherapy for patients with favorable-risk prostate cancer

IJROBP 2014;90(5):1069-75

Find this article


#67

Smith, G
Brachytherapy Improves biochemical failure- free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a proprensity score matched analysis.

IJROBP 2015;91(3):505-16

Find this article


#68

Smith, G
Brachytherapy Improves biochemical failure- free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a proprensity score matched analysis.

IJROBP 2015;91(3):505-16

Find this article


#69

Soares, R
Minimum 5-year follow-up of 1138 consecutive laparoscopic radical prostatectomies.

BJU Int. 2015;115():546-53

Find this article


#70

Sooriakumaran, P
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a Minimum Follow-up Time of 5 Years

Eur Urol 2012;62(5):768-74

Find this article


#71

Spratt, DE
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer

IJROBP 2013;85(3):686-92

Find this article


#72

Stone, N
Local control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes

IJROBP 2010;76(2):355-360

Find this article


#73

Surapaneni, A
Radiation therapy for clinically localized prostate cancer: Long-term results of 469 patients from a single institution in the era of dose escalation.

J Ca Res Ther 2014;10(4):951-56

Find this article


#74

Sylvester, J
FIFTEEN-YEAR BIOCHEMICAL RELAPSE-FREE SURVIVAL, CAUSE-SPECIFIC SURVIVAL, AND OVERALL SURVIVAL FOLLOWING I125 PROSTATE BRACHYTHERAPY IN CLINICALLY LOCALIZED PROSTATE CANCER: SEATTLE EXPERIENCE

IJROBP 2011;81(2):376-81

Find this article


#75

Taira, A
Natural History of Clinically Staged Low- and Intermediate Risk Prostate Cancear Treated With Monotherapeutic Permanent Interstitial Brachytherapy

IJROBP 2010;76(2):349-354

Find this article


#76

Thaker, N.G.
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing

Brachytherapy 2016;15(3):274-82

Find this article


#77

Thames, H
Increasing External Beam Dose for T1-T2 Prostate Cancer: Effect on Risk Groups

Int. J. Rad Onc/Bio 2006;65(4):975-981

Find this article


#78

Thüroff, S
Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years

J Urol 2013;190(2):702-10

Find this article


#79

Uchida
(Group #1)Improved Outcomes with advancements in high intensity focused ultrasound devices for the treatment of localized prostate cancer.

J Urol 2015;193(1):103-10

Find this article


#80

Vargas, C
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy

Brachytherapy 2013;12(2):120-5

Find this article


#81

Vora, S
Nine-year outcome and toxicity in patients treated with IMRT for localized prostate cancer

J Urol 2013;In Press(02/06/2013 00:00:00):

Find this article


#82

Weight, C
Limited pelvic lymph node dissection does not improve biochemical relapse free survival at 10-years after radical prostatectomy in patients with low risk prostate cancer

J. Urology 2008;71(1):141-145

Find this article


#83

Yamada, Y
Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.

Brachytherapy 2015;14(2):118-23

Find this article


#84

Yorozu, A
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as predicted in Japan: Outcomes of 1300 patients

Brachytherapy 2015;14(2):111-17

Find this article


#85

Zelefsky, M J
Comparison of Tumor Control and Toxicity outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer

Urology 2010;In Press():

Find this article


#86

Zelefsky, M J
Comparison of Tumor Control and Toxicity outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer

Urology 2010;In Press():

Find this article


#87

Zelefsky, M
Long Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer

J. Urology 2006;176(4):1415-1419

Find this article


#88

Zelefsky, m
Five-Year Outcome of Intraoperative Conformal Permanent I-125 Interstitial Implantation for Patients With Clinically Localized Prostate Cancer

IJROBP 2007;67(1):65-70

Find this article


#89

Zelefsky, m
long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation in biochemical tumor control and distant metastases-free survival outcomes

IJROBP 2008;71(4):1028-1033

Find this article


#90

Zietman, A
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adencarcinoma of the Prostate

JAMA 2005;294(10):1233-1276

Find this article


#91

Zietman, A
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

J. Clinical Oncology 2010;28(7):1106-1111

Find this article